Featured Strategy

Mirae Asset

Allocation among commodities, equity and debt ETFs for a balanced multi-asset growth approach.

Learn more
CategoryMulti-Asset Allocation
No. of ETFs4 ETFs
Review CycleMonthly Review
Horizon3–5 Years

Performance

How this portfolio has performed

Compare growth against a benchmark across timelines and see what a hypothetical investment would be worth today.

In the period of
Amount (₹)00.5K1K1.5K2K2.5KOctDecFebAprJunAugTime

Overview

Understand this portfolio

Key metrics, suitability, and strategy highlights to help you evaluate whether this model portfolio fits your goals.

Investment Objective

Balanced multi-asset growth

Combine equity, debt, and gold in one rules-based portfolio for balanced long-term growth. Diversification across asset classes helps reduce dependence on any single market outcome.

No. of ETFs

4 ETFs

Suggested Horizon

3–5 Years

Review Cycle

Monthly

Min. Investment

₹10,000

Who this may be suitable for

Investors looking for a diversified mix across equity, debt, and gold who prefer a single portfolio rather than managing multiple asset classes separately.

What investors should keep in mind

Multi-asset portfolios can still experience drawdowns during market stress. Allocation shifts may not fully offset losses in any one asset class.

  • Diversified across equity, debt, and gold
  • Disciplined asset allocation framework
  • Monthly review and rebalance cycle
  • Built for long-term wealth creation

Holdings

Portfolio constituents and weights

Review the ETF mix and segment allocation that defines this model portfolio.

Log in to view holdings and allocation details

FAQs

Got questions? We've got answers!

Common questions about Mirae Asset Multi Asset and what to expect when you invest.

Mirae Asset Multi Asset is a diversified ETF model portfolio spread across equity, debt, and gold. It is built for investors who want one rules-based allocation instead of managing multiple asset sleeves separately.

Collateral

Documents and timelines

Download portfolio documents and review the scheduled rebalance checkpoints for this strategy.

Rebalance Timelines

  • Q1 Review — January 2026

    Quarterly allocation check against model targets and drift thresholds.

  • Q2 Review — April 2026

    Mid-year review of macro signals, risk metrics, and sleeve performance.

  • Q3 Review — July 2026

    Thematic and factor sleeve review with updated market regime assessment.

  • Q4 Review — October 2026

    Year-end reset to target weights and annual strategy documentation update.